RECRUITING

PediRISE Feasibility

Talk to us

Conditions

Pediatric CancerFinancial StressFinancial HardshipDisparities

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this research study is to learn whether investigators can successfully give the PediRISE program to families-in other words, whether most families are interested in participating in a study about the PediRISE program, including a 50-50 chance of receiving standard usual care, and a 50-50 chance of receiving the PediRISE support program. The names of the study groups in this research study are: * PediRISE Program Group * Usual Care Group

Official Title

Pilot Randomized Pediatric RISE (Resource Intervention to Support Equity) Feasibility Study

Quick Facts

Study Start:2024-05-15
Study Completion:2024-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06283251

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:Not specified to 17 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. * Child diagnosed with de novo cancer
  2. * Child has established care at a study site and initiated cancer-directed therapy in the prior 2-months
  3. * Child planned to receive at least 4-months of cancer-directed therapy at study site from time of diagnosis per initial cancer treatment plan
  4. * Child is \<18 years at time of enrollment
  5. * Parent/guardian screened positive for self-reported low-income (\<200% FPL).
  6. * Family primary residence in MA, NY or NJ
  7. * Provider approval for permission to approach
  1. * Planned transfer of child to a non-DFCI or non-Columbia facility for cancer-directed therapy
  2. * Foreign national family receiving care as an Embassy-pay patient
  3. * Child is enrolled on embedded correlative health equity aims of open or upcoming clinical drug trials which are powered on descriptive parent-reported poverty data (e.g. AALL1731, AHOD2131, ANBL2131, DFCI 23-001).
  4. * Child or household member receiving SSI.

Contacts and Locations

Study Contact

Kira Bona, MD, MPH
CONTACT
617-632-4688
Kira_Bona@dfci.harvard.edu

Principal Investigator

Kira Bona, MD, MPH
PRINCIPAL_INVESTIGATOR
Dana-Farber Cancer Institute

Study Locations (Sites)

Boston Children's Hospital
Boston, Massachusetts, 02215
United States
Dana Farber Cancer Institute
Boston, Massachusetts, 02215
United States

Collaborators and Investigators

Sponsor: Dana-Farber Cancer Institute

  • Kira Bona, MD, MPH, PRINCIPAL_INVESTIGATOR, Dana-Farber Cancer Institute

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-05-15
Study Completion Date2024-12-31

Study Record Updates

Study Start Date2024-05-15
Study Completion Date2024-12-31

Terms related to this study

Keywords Provided by Researchers

  • Pediatric Cancer
  • Financial Stress
  • Financial Hardship
  • Disparities

Additional Relevant MeSH Terms

  • Pediatric Cancer
  • Financial Stress
  • Financial Hardship
  • Disparities